Chronic musculoskeletal pain
Conditions
Interventions
exposed group (Bulleyaconitine A Tablets:NA
Non-exposed group (Duloxetine hydrochloride enteric coated capsules):NA
Sponsors
The Third Affiliated Hospital of Beijing University of Chinese Medicine/Hebei Medical University Third Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for chronic musculoskeletal pain; 2. Meet the diagnostic criteria for chronic lower back pain; 3. The most painful VAS score within 24 hours before enrollment is = 4 points; 4. Age >= 18 years old;
Exclusion criteria
Exclusion criteria: 1. Excluding those who are allergic or contraindicated to Bulleyaconitine A Tablets and Duloxetine hydrochloride enteric coated capsules; 2. Pregnant and lactating women are prohibited from using it; 3. Excluding primary diseases such as severe cardiovascular, cerebrovascular, liver, kidney, hematopoietic system, tumors, and psychiatric patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Oswestry(ODI);ID Pain;EQ-5D-5L;Quantitative grading of clinical symptoms/syndromes;Pain rebound rate during follow-up period; | — |
Countries
China
Contacts
Public ContactChen Weiheng/Hou zhiyong
The Third Affiliated Hospital of Beijing University of Chinese Medicine/HEBEI MEDICAL UNIVERSITY THIRDHOSPITAL
Outcome results
None listed